The Critical Medicines Alliance workspace serves as a central hub for collaboration and industrial policy action by strengthening the supply of critical medicines across the EU. The members of the Alliance will identify key areas and priorities, recommending long-term industrial policy solutions to prevent and address medicine shortages and challenges in the supply chains.
General
Working groups
Identifies vulnerabilities and challenges in critical medicine supply chains and pinpoints opportunities to strengthen the EU industrial base by enhancing production capabilities and securing a steady supply of critical medicines to meet demand.
Mitigates the risks associated with geographic concentration of global manufacturing capacities by developing and deepening international partnerships.